Fact CheckerSign in

NCT07730268Enrolling by invitation

Vivio At-Home Study

Evaluation of a Novel, Non-Invasive Approach to Estimating Pulmonary Artery Pressure as an Alternative Method for Tracking Heart Failure Status

Source: ClinicalTrials.gov · Last updated 28 Jul 2026

Brief summary (registry, in English)

The purpose of the study is to examine the Vivio System's ability to track heart failure status in subjects, and compare the Vivio System's measurements to CardioMEMS measurements. Heart failure, which is a form of heart disease, is a condition where the heart does not pump enough blood through the body, resulting in the body not getting the amount of oxygen and nutrients it needs. This research study will collect data using CardioMEMS and the Vivio System in subjects over the age of 21 with a currently implanted, or scheduled to be implanted, CardioMEMS device. This group of individuals will provide researchers with important data because the measurements of their health information can be used to determine if the Vivio is as effective at tracking heart failure status as CardioMEMS. This research study is designed to develop new knowledge, and does not provide a direct benefit to study subjects

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
500 (estimated)
First submitted
14 Jul 2026
Start date
20 Oct 2025
Primary completion date
31 Dec 2028
Lead sponsor
Ventric Health, LLC
NCT number
NCT07730268

What you commit to

  • Study type: Interventional
  • Planned participants: 500
  • From 20 Oct 2025 to the primary completion date, 31 Dec 2028
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Open skin lesions at the site of Vivio application / examination.
  • Inability to obtain brachial artery blood pressure.

Who the study is looking for

  • Adult subjects over the age of 21.
  • A CardioMEMS HF System implanted or scheduled to be implanted.
  • 70% or more signal strength from CardioMEMS at the time of enrollment.
  • Ability to successfully obtain a Vivio System measurement.
  • Willing and able to participate in all study evaluations and allow access to medical records, including medical testing records up to 2 years after completion of the study.
  • Ability to understand and sign informed consent.

Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
MemorialCare Long Beach Medical Center
Coordinator of this site? Confirm its status
Long BeachUnited StatesUnknown status
USC Keck School of Medicine
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
Renown Regional Medical Center
Coordinator of this site? Confirm its status
RenoUnited StatesUnknown status
UC San Diego School of Medicine
Coordinator of this site? Confirm its status
San DiegoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.